Fig. 3.
The soluble GM-CSF receptor is found in plasma conditioned by human hematopoietic progenitor cells.
Plasma conditioned by PBSC products was subjected to Con-A sepharose and ligand affinity column chromatography. Pooled fractions from the ligand affinity column were dialyzed against distilled H2O lyophilized, and then resuspended in 500 μL PBS for analysis. Samples 1, 5, 6 = donors for autologous transplant. Samples 2, 3, 4 = donors for allogeneic transplant. Panel A: 25 μL sample from each donor was used in 125I-GM-CSF solution phase binding assays in the absence or presence of a large excess of unlabeled GM-CSF. Specifically bound radioactivity (spec bound, cpm) was calculated by subtracting the precipitated radioactivity in the absence of unlabeled GM-CSF from that in the presence of unlabeled GM-CSF. Bars represent the mean and SEM of duplicate experiments. Panel B: 30 μL sample from each donor was subjected to 10.5% SDS PAGE under reducing conditions and transferred to PVDF membrane. Immunoblotting was performed with anti-GMRα antibody 8G6. Positive control (+ve) was ligand affinity purified recombinant solGMRα. Negative control (-ve) was sham ligand affinity column eluate. The position of the molecular weight markers is shown in kilodaltons.